Accelerating Drug Discovery for Frontotemporal Degeneration
The ADDF Academic Drug Discovery and Development Program seeks to create and support innovative translational research programs for Alzheimer’s disease, related dementias and cognitive aging in academic medical centers and universities. Biomarker development studies and innovative proof of concept pilot clinical trials of new approaches to treatment, prevention and early detection are also supported.
Amount: $ 150,000
Deadline: LOI august 22, 2015
Burroughs Wellcome has issued an RFP for its Career Awards for Medical Scientists program. http://www.bwfund.org/grant-programs/biomedical-sciences/career-awards-medical-scientists
Pre-proposals are due August 5th. In a nutshell, the program provides $700,000 over five years (no indirect) for postdocs/fellows/residents in order to support the transition from postdoctoral/fellowship training to the early years of faculty service. Proposals must be in the area of basic biomedical, disease-oriented, or translational research. Proposals in the reproductive sciences are encouraged, and two awards will be made to research bridging psychiatry and neuroscience. Woman and under-represented minorities are strongly encouraged to apply. There is no limit on the number of pre-proposals that can be submitted by each institution.
For awardees that may move from one institution to another mid-award, this award is portable. Eligibility requirements:
- Ideal candidate will have at least two years of postdoc research experience and be two years away from becoming an independent investigator, be a first author in a high-impact journal, and have a significant publication record.
- Applicants must have institutional approval.
- Applicants must be fellows, residents, or postdocs and hold an MD, DDS, DVM, or DO degree – and have received their clinical doctorate degree on or after 1/1/04. Assistant professors are not eligible.
- Applicants must be citizens or permanent residents of the U.S.
The American Heart Association funds research broadly related to cardiovascular disease and stroke. The objective of the National Established Investigator Award is to support mid-term investigators with unusual promise and an established record of accomplishments; candidates have a demonstrated commitment to cardiovascular or cerebrovascular science as indicated by prior publication history and scientific accomplishments. A candidate’s career is expected to be in a rapid growth phase.
Amount: $ 400,000
Deadline: July 21, 2015
This award is designed to provide support for the next generation of exceptionally creative thinkers with “high-risk/high-reward” ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field.
Amount: $ 300,000-600,000
Deadlines: July 1, 2015
RPB Unrestricted and Challenge Grants
RPB’s mission is to preserve and restore vision by supporting research to develop treatments, preventives and cures for all conditions that damage and destroy sight. RPB Offers grants high-potential investigators at any stage of their careers, from medical students to seasoned investigators expanding the frontiers of vision care.
Amount: $ 115,000-300,000
Deadlines: July 1, 2015
Post Doctoral Research Fellowships
The foundation supports early postdoctoral research training in all basic biomedical sciences. To attain its ultimate goal of increasing the number of imaginative, well-trained and dedicated medical scientists, the Foundation grants financial support of sufficient duration to help further the careers of young men and women engaged in biological or medical research.
Amount: $ 156,000
Deadline: July 1, 2015
The Bio-Therapeutics Impact Award accelerates the development of clinical trials for promising biologic approaches to treating childhood cancer. These approaches include, but are not limited to, immunotherapy, gene therapy and small molecules. The award is intended for investigators who are initiating clinical trials or undertaking the pre-clinical work necessary to move into the IND (investigational new drug) phase.
Deadline: June 30, 2015
Deadline: May 18, 2015
The Developmental Disabilities Translational Research Program supports researchers in developing treatments and improving outcomes for individuals with developmental disabilities, particularly Down syndrome and Fragile X syndrome (and FX associated disorders). The awards are made to the most highly innovative translational research projects that have the greatest potential of investigating rational and effective treatments and interventions for the particular condition being addressed. The program emphasizes interdisciplinary collaborative grant applications focused primarily on FXS and DS, but the program supports studies focused on other developmental disabilities under special circumstances..
Deadline: May 18, 2015
SIG Pre-submission Process
The Shared Instrument Grant (SIG) program encourages applications from groups of NIH-sponsored investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $50,000. Types of instruments supported include, but are not limited to: X-ray diffraction systems, nuclear magnetic resonance (NMR) and mass spectrometers, DNA and protein sequencers, biosensors, electron and confocal microscopes, cell-sorters and biomedical imagers.
The office of the Associate Dean for Research, BUSM will facilitate an internal SIG pre-submission process to foster collaborative proposals and increase the success rate for the University. This pre-submission process requires that applicants fill out an online form designed inform Dr. Antman, BUSM Dean and BUMC Provost of your interest in applying for an S10 Shared Instrumentation Grant.
The proposals will be routed to the Core Advisory Committee, who will assist the Associate Dean for Research, BUSM and the Provost with evaluating scientific merit and ensuring that highly-rated applications receive the appropriate level of institutional support to make them most competitive.
This process will:
- Identify the necessary level of institutional support needed for a competitive application.
- Identify any potential space and renovation needs ahead of the application.
- Help obtain access to equipment, or equipment loans, in order to generate additional data to strengthen the application if needed.
- Alert other members of the research community who may be important additions to the users group, and ensure transparency of the SIG process.
- Ensure that we do not have competing applications for similar equipment.
This process is not intended to prevent submission of applications, but to recognize that when multiple applications are being submitted, it may not be possible to centrally support all of them at a competitive level from the Provost’s or the Deans’ resources, providing the opportunity to identify alternative sources of funding.
If you are considering submitting a SIG in 2015, please fill out the SIG pre-submission online form as soon as possible. The internal submission deadline university-wide is March 9
The Massachusetts Life Sciences Center’s Cooperative Research Matching Grant Program is providing funding of up to $250,000 per year for two years, for projects that advance “industry-academic research collaborations, support translational research, and accelerate the commercialization of promising products and services.” The industry partner is required to provide 1:1 matching funds.
Applications are due February 13th. http://www.masslifesciences.com/programs/crmg/
Any researchers interested in this opportunity should contact:
Director of Foundation Relations
Boston University School of Medicine
72 E. Concord Street, Suite L219
Boston, MA 02118